R B Govindan1, A N Massaro2, Adre du Plessis3. 1. Division of Fetal and Transitional Medicine, Children's National Health System, 111 Michigan Ave, NW, Washington, DC', 20010, USA. Electronic address: rgovinda@childrensnational.org. 2. Division of Fetal and Transitional Medicine, Children's National Health System, 111 Michigan Ave, NW, Washington, DC', 20010, USA; Division of Neonatology, Children's National Health System, 111 Michigan Ave, NW, Washington, DC, 20010, USA. 3. Division of Fetal and Transitional Medicine, Children's National Health System, 111 Michigan Ave, NW, Washington, DC', 20010, USA.
Abstract
BACKGROUND: Near infrared spectroscopy (NIRS) derived hemoglobin difference (HbD: oxygenated [HbO2] - reduced hemoglobin [Hb]) and total hemoglobin (HbT: HbO2+Hb) have been used as surrogate measures of cerebral blood flow and volume, respectively. Statistically, a lack of HbD-blood pressure (BP) or negative HbT-BP association is regarded as a state of intact cerebral pressure autoregulation (CPA). In contrast, a co-variation of HbD/HbT and systemic blood pressure (BP) in the same direction is thought of as a failure of CPA. If the quality of one (NIRS/BP) or both signals is compromised, the reliability of the results may be adversely affected. In this work, we develop an analytic approach to assess the quality of the NIRS signals. NEW METHOD: Given that cardiac pulses cause hemodynamic changes that are transmitted through the peripheral vasculature, cerebral NIRS signals should exhibit cyclical changes at the pulse frequency. Therefore, we propose that an association between HbD/HbT and electrocardiogram (EKG) signals would be an indicator of NIRS quality. We demonstrate the application of this approach with data collected from six newborns undergoing therapeutic hypothermia for neonatal encephalopathy. RESULTS: We observed an intermittent lack of association between NIRS signals and EKG data over the course of several hours of continuous records, indicating a loss in the strength in NIRS signals. COMPARISON WITH EXISTING METHOD: Existing CPA characterization suffers from Type-II error which the current preprocessing approach can mitigate. CONCLUSIONS: The proposed approach will allow for real-time assessment of NIRS signal quality that is essential for accurate CPA monitoring.
BACKGROUND: Near infrared spectroscopy (NIRS) derived hemoglobin difference (HbD: oxygenated [HbO2] - reduced hemoglobin [Hb]) and total hemoglobin (HbT: HbO2+Hb) have been used as surrogate measures of cerebral blood flow and volume, respectively. Statistically, a lack of HbD-blood pressure (BP) or negative HbT-BP association is regarded as a state of intact cerebral pressure autoregulation (CPA). In contrast, a co-variation of HbD/HbT and systemic blood pressure (BP) in the same direction is thought of as a failure of CPA. If the quality of one (NIRS/BP) or both signals is compromised, the reliability of the results may be adversely affected. In this work, we develop an analytic approach to assess the quality of the NIRS signals. NEW METHOD: Given that cardiac pulses cause hemodynamic changes that are transmitted through the peripheral vasculature, cerebral NIRS signals should exhibit cyclical changes at the pulse frequency. Therefore, we propose that an association between HbD/HbT and electrocardiogram (EKG) signals would be an indicator of NIRS quality. We demonstrate the application of this approach with data collected from six newborns undergoing therapeutic hypothermia for neonatal encephalopathy. RESULTS: We observed an intermittent lack of association between NIRS signals and EKG data over the course of several hours of continuous records, indicating a loss in the strength in NIRS signals. COMPARISON WITH EXISTING METHOD: Existing CPA characterization suffers from Type-II error which the current preprocessing approach can mitigate. CONCLUSIONS: The proposed approach will allow for real-time assessment of NIRS signal quality that is essential for accurate CPA monitoring.
Authors: Heather O'Leary; Matthew C Gregas; Catherine Limperopoulos; Irina Zaretskaya; Haim Bassan; Janet S Soul; Donald N Di Salvo; Adré J du Plessis Journal: Pediatrics Date: 2009-07 Impact factor: 7.124
Authors: Jennifer K Lee; Ken M Brady; Shang-En Chung; Jacky M Jennings; Emmett E Whitaker; Devon Aganga; Ronald B Easley; Kerry Heitmiller; Jessica L Jamrogowicz; Abby C Larson; Jeong-Hoo Lee; Lori C Jordan; Charles W Hogue; Christoph U Lehmann; Mela M Bembea; Elizabeth A Hunt; Raymond C Koehler; Donald H Shaffner Journal: Resuscitation Date: 2014-07-18 Impact factor: 5.262
Authors: Kenneth Brady; Brijen Joshi; Christian Zweifel; Peter Smielewski; Marek Czosnyka; R Blaine Easley; Charles W Hogue Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: An N Massaro; R B Govindan; Gilbert Vezina; Taeun Chang; Nickie N Andescavage; Yunfei Wang; Tareq Al-Shargabi; Marina Metzler; Kari Harris; Adre J du Plessis Journal: J Neurophysiol Date: 2015-06-10 Impact factor: 2.714
Authors: Haim Bassan; Kimberlee Gauvreau; Jane W Newburger; Miles Tsuji; Catherine Limperopoulos; Janet S Soul; Gene Walter; Peter C Laussen; Richard A Jonas; Adré J du Plessis Journal: Pediatr Res Date: 2004-11-05 Impact factor: 3.756
Authors: Thomas Heldt; Faisal M Kashif; Mustafa Sulemanji; Heather M O'Leary; Adré J du Plessis; George C Verghese Journal: Acta Neurochir Suppl Date: 2012
Authors: Rathinaswamy Bhavanandhan Govindan; An N Massaro; Nickie N Andescavage; Taeun Chang; Adré du Plessis Journal: Front Hum Neurosci Date: 2014-04-24 Impact factor: 3.169
Authors: An N Massaro; Jennifer K Lee; Gilbert Vezina; Penny Glass; Alexandra O'Kane; Ruoying Li; Taeun Chang; Kenneth Brady; Rathinaswamy Govindan Journal: Neurocrit Care Date: 2020-11-20 Impact factor: 3.532